MDS Presentations

Keynote Lecture
The Role of Innate Immunity in MDS Pathogenesis
Alan List, M.D., Moffit Cancer Center

WHO MDS Classification
Katherine Calvo, M.D., Ph.D., Clinical Center, NIH

Overview of MDS Standard Therapy
Catherine Lai, M.D., Lombardi Cancer Center

Somatic and Germ Line Mutations in AML
Paul Liu, M.D., Ph.D., National Human Genome Research Institute, NIH

Current Status and Advances in MRD Measurement (presentation not available)
Christopher Hourigan, M.D., D.Phil., National Heart, Lung, and Blood Institute
Laura Dillon Ph.D., National Heart, Lung, and Blood Institute

Preclinical Myeloid Leukemia Models
Peter Aplan, M.D., Center for Cancer Research, NCI

Novel HMAs and Combinations (presentation not available)
Steven Grant, M.D., Virginia Commonwealth University

CTEP AML/MDS Precision Medicine Initiative
Rich Little, M.D., Division of Cancer Treatment and Diagnosis, NCI

Heterogeneity in Refractory AML
Michael Gottesman, M.D., Center for Cancer Research, NCI

Targeting HMA Refractory MDS
Daniel Larson, Ph.D., Center for Cancer Research, NCI

Strategies to Enhance Effects of Cellular Immunotherapy
Jack Shern, M.D., Center for Cancer Research, NCI

NK Cell Therapy for Myeloid Leukemia
Kate Stringaris, M.D., Ph.D., National Heart, Lung and Blood Institute, NIH

Chemotherapy Induced AML in Modern Era
Lindsay Morton, Ph.D., Division of Cancer Epidemiology and Genetics, NCI

DCTD Phase 1 Program
Geraldine O’Sullivan, M.D., Ph.D., Division of Cancer Treatment and Diagnosis, NCI

Clofarabine and Bortezomib Phase 1 Study
Naoko Takebe, M.D., Ph.D., Division of Cancer Treatment and Diagnosis, NCI
Sabrina Khan, M.D., MPH, Center for Cancer Research, CCR

CSF1R Blockade
Rosandra Kaplan, M.D., Center for Cancer Research, NCI

MUD RIC Transplant for Hematologic Malignancy
Steven Pavletic, M.D., M.S., Center for Cancer Research, NCI

Haplo-Identical Donor Transplant for Hematologic Malignancy
Christopher Kanakry, M.D., Center for Cancer Research, NCI

CAR-T Cells for Acute Leukemia
Nirali Shah, M.D., Center for Cancer Research, NCI

Allogeneic Transplant for GATA2 Mutation
Mark Parta, Ph.D., National Institute of Allergy and Infectious Diseases, NIH

RUNX1 Clinic and Transplant Protocols
Lea Cunningham, M.D., National Human Genome Research Institute, NCI

Other Inherited Leukemias
Lisa McReynolds, M.D., Ph.D., Division of Cancer Epidemiology and Genetics, NCI